Replies to post #24683 on BioSante Pharmaceuticals, Inc. (BPAX)

[Jeffqdh]

Hi Jadite,


So Bpax spent a few hundred million for efficacy ? The real cost here was to establish proven safety,

If this merger is approved, and i don't think it will be, should be,

we are looking at a 1-4 or more RS then dilution to follow, the combined Co is cash poor !


Would they be going after retail investors for votes if institutional investors were voting yes ?

I respect your opinion, IMO there is only one reason for a low evaluation , and its not to benefit shareholders, Forget about what they are saying now,


Look closely at what they have done ! Throughout 2012 is was very obvious to me that there was in fact a deliberate attempt to suppress the value of our assets , JMHO